Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425016 · ClinicalTrials.gov registry record · NA
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
A NA study of Obesity and Postoperative Pain, sponsored by Ricard Corcelles.
- Recruiting
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT06425016: Recruiting NA study of Obesity and Postoperative Pain, sponsored by Ricard Corcelles.
NCT06425016 is a NA study of Obesity and Postoperative Pain that is actively recruiting participants, run by Ricard Corcelles. The registered enrollment target is 91 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425016, a NA study of Obesity and Postoperative Pain, is actively recruiting participants, sponsored by Ricard Corcelles.
- RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a prospective, obesity-registry based, single-blind randomized controlled trial with a 1:1 allocation ratio. Specific inclusion criteria are all patients eligible to undergo a Laparoscopic sleeve gastrectomy (LSG) based on the current National Institute of Health (NIH) patient selection guidelines. Patients should be able to give consent, be deemed medically-cleared to undergo elective surgery, and tolerate general anesthesia. All enrollments and surgeries in this study will take place at the Cleveland Clinic Bariatric and Metabolic Institute. The study will consist of 2 interventions: laparoscopic sleeve gastrectomy (LSG) or robotic sleeve gastrectomy (RSG). The primary objective is early postoperative pain, but also surgeon ergonomics and patient quality of life will be compared. Additional outcomes include 30-day perioperative results, minor and major morbidities, serious adverse events, resolution of medical comorbidities, and weight loss in percent of excess weight lost (%EWL) at one year.
Primary Outcome
To determine if patients with obesity planned for robotic sleeve gastrectomy experience a decrease in opioid consumption (Morphine Equivalent Dose) in mg on postoperative day 1 compared to patients undergoing laparoscopic sleeve gastrectomy.
Conditions Studied
Interventions
- PROCEDURE Laparoscopic Sleeve Gastrectomy (LSG)
- PROCEDURE Robotic Sleeve Gastrectomy (RSG)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT06425016 shows while recruiting
NCT06425016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower).
The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Laparoscopic Sleeve Gastrectomy (LSG) is the first listed.
NCT06425016 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06425016 about?
NCT06425016 is a clinical study titled "Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy". This will be a prospective, obesity-registry based, single-blind randomized controlled trial with a 1:1 allocation ratio. Specific inclusion criteria are all patients eligible to undergo a Laparoscopic sleeve gastrectomy (LSG) based on the current National Institute of Health (NIH) patient selection...
What is the current status of trial NCT06425016?
This trial is currently recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2024-07-17. Estimated completion is 2027-04-30.
What conditions does trial NCT06425016 study?
This clinical trial studies the following conditions: Obesity, Postoperative Pain, Quality of Life, Bariatric Surgery Candidate, Laparoscopic Sleeve Gastrectomy.
What interventions are being tested in trial NCT06425016?
The interventions under investigation include: Laparoscopic Sleeve Gastrectomy (LSG) (PROCEDURE), Robotic Sleeve Gastrectomy (RSG) (PROCEDURE).
Who is sponsoring clinical trial NCT06425016?
This trial is sponsored by Ricard Corcelles, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425016 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06425016's enrollment target sits among peer trials
91 519th of 1053 higher than 535 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI